A third quality assured, generic DMPA-IM product available for procurement
A third quality assured, generic DMPA-IM contraceptive product available for procurement
Oct
2019
29
May
2019
22
World Preeclampsia Day – Access to quality magnesium sulfate to reduce maternal mortality
Access to quality magnesium sulfate and implementation of guidelines can help reduce maternal deaths due to preeclampsia. When a mother dies, the impact of her death reaches much further than the individual tragedy. It affects the life and health of the family,...
Mar
2019
28
WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health
Appropriate Storage and Management of Oxytocin - a Key Commodity for Maternal Health
Dec
2018
18
Access to Quality Assured generic Intramuscular DMPA continues to rise
Access to Quality Assured generic Intramuscular DMPA continues to rise
Aug
2018
31
“The Case for Quality” report
Following the highly successful “Incentivising Investments in Quality Medicines” event at the World Health Assembly, USP and partners in the #MedsWeCanTrust Campaign have released a report into the learnings from the event. As a #MedsWeCanTrust partner, we are happy to share the report: The Case for Quality.
Jul
2018
19
New generic IM DMPA available for procurement
Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
Apr
2016
29
Quality Matters: Cheap Uterotonics – Bargain or Burden?
Fiona Theunissen, MBA and Dr Hans Vemer, CEO of Concept Foundation and former obstetrician, discuss why quality, which is by no means a given, is such an important consideration when purchasing maternal health medicines such as uterotonics.
